Medical Health Encyclopedia

Osmotic fragility


InjuryDiseasesNutritionPoison
SymptomsSurgeryTestSpecial Topic
Overview Results Risks Prevention
Definition

Osmotic fragility is a test to detect whether red blood cells are more likely to break down.


How the test is performed

Blood is typically drawn from a vein, usually from the inside of the elbow or the back of the hand. The site is cleaned with germ-killing medicine (antiseptic). The health care provider wraps an elastic band around the upper arm to apply pressure to the area and make the vein swell with blood.

Next, the health care provider gently inserts a needle into the vein. The blood collects into an airtight vial or tube attached to the needle. The elastic band is removed from your arm. Once the blood has been collected, the needle is removed, and the puncture site is covered to stop any bleeding.




In infants or young children, a sharp tool called a lancet may be used to puncture the skin and make it bleed. The blood collects into a small glass tube called a pipette, or onto a slide or test strip. A bandage may be placed over the area if there is any bleeding.

In the laboratory, red blood cells are tested with a solution that makes them swell, in order to determine how fragile they are.


How to prepare for the test

No special preparation is necessary for this test.


How the test will feel

When the needle is inserted to draw blood, some people feel moderate pain, while others feel only a prick or stinging sensation. Afterward, there may be some throbbing.


Why the test is performed

This test is performed to detect hereditary spherocytosis and thalassemia. Hereditary spherocytosis makes red blood cells more fragile than normal. Some red blood cells in patients with thalassemia are more fragile than normal, but a larger number are less fragile than normal.



Review Date: 03/21/2010
Reviewed By: Linda J. Vorvick, MD, Medical Director, MEDEX Northwest Division of Physician Assistant Studies, University of Washington, School of Medicine; James R. Mason, MD, Oncologist, Director, Blood and Marrow Transplantation Program and Stem Cell Processing Lab, Scripps Clinic, Torrey Pines, California. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.

A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org).

Find a Therapist
PR Newswire